The Patent Finder

Terms ending in 2035

Torqur AG

Every in-force patent on Torqur AG's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,100,031Novel Manufacturing Process for Triazine, Pyrimidine and Pyridine Derivatives
In force
 · High confidence
Torqur AGIn forceHigh confidence
US 10,766,874Novel Manufacturing Process for Triazine, Pyrimidine and Pyridine Derivatives
In force
 · High confidence
Torqur AGIn forceHigh confidence
US 10,640,516Difluoromethyl-Aminopyridines and Difluoromethyl-Aminopyrimidines
In force (reinstated)
 · High confidence
Torqur AGIn force (reinstated)High confidence
US 11,186,591Difluoromethyl-Aminopyridines and Difluoromethyl-Aminopyrimidines
In force
 · High confidence
Torqur AGIn forceHigh confidence
US 11,878,972Treatment of Neurological Disorders
In force
 · Low confidence
Piqur Therapeutics AGIn forceLow confidence
5 of 5 patents shown. Soonest term end first, then patent number.
4 of these are in force and held by Torqur AG.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited